FDA Person
FDAChristopher J. Adams
View detailed information about Christopher J. Adams, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Christopher J. Adams, including their role, qualifications, and regulatory activities.
Recent Records (23)
Page 1 of 2EIR - Musculoskeletal Transplant Foundation, Inc.
EIR
RESUME - Unknown Company
RESUME
483 - Columbus Ctr for Repro. Endo & Infertility, LLC
483
483 - Vitalant
483
483 - West TN Regional Blood Center, dba Lifeline Blood Services
483
483 - DCI Donor Services Tissue Bank
483
EIR - Cardinal Health dba Specialty Pharmaceutical Services
EIR
483 - Center for Reproductive Health Fertility Laboratory of Nashville
483
483 - Merck Sharp & Dohme LLC
483
483 - Center for Reproductive Health Fertility Laboratory of Nashville
483
483 - Vivex Biologics, Inc.
483
483 - LifeSouth Community Blood Centers, Inc
483
483 - National Embryo Donation Center
483
483 - MiMedx Group, Inc.
483
EIR - Merck Sharp & Dohme LLC
EIR
483 - MiMedx Group, Inc.
483
483 - Biomat USA Inc
483
483 - Southern Blood Services Inc
483
483 - MiMedx Group, Inc.
483
483 - Center for Reproductive Health Fertility Laboratory of Nashville
483
Showing 1-20 of 23 records
Person Information
Name
Christopher J. Adams
Role
ISSUING OFFICER
ID: f7010846-7fd1-4ee8-901a-1015656fea0a
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.